Skip to main content Accessibility help
  • Print publication year: 2000
  • Online publication date: June 2014

Chapter 21 - The lungs in connective tissue disease


Introduction to connective tissue diseases

Pleuropulmonary involvement by connective tissue diseases (CTD) is varied and includes pleural, interstitial, bronchial/bronchiolar and vascular manifestations. Common patterns of involvement overlap with those of idiopathic lung disease. They include patterns of nonspecific interstitial pneumonia (NSIP), lymphocytic interstitial pneumonitis (LIP), organizing pneumonia (OP), usual interstitial pneumonia (UIP), diffuse alveolar damage (DAD), chronic bronchiolitis, pulmonary capillaritis with alveolar hemorrhage and primary pulmonary hypertension among others (see Table 1). Some patterns (e.g. OP and NSIP) can occur in all CTD although their incidences, as pulmonary manifestations, differ greatly between individual disorders. This chapter reviews common and rare pulmonary manifestations of CTDs. Radiological and histological features of individual patterns of interstitial lung disease (e.g. NSIP pattern) are similar to those of their idiopathic counterparts (see Chapter 10). Accordingly this chapter will refer to such patterns but will not repeat detailed descriptions of the pathology. The status of Behçet syndrome, inflammatory bowel disease, as well as some dermatological conditions (e.g. Sweet syndrome, pyoderma gangrenosum) as components of CTD is less clear. They may have pulmonary and other systemic manifestations and are also briefly discussed.

Related content

Powered by UNSILO
Travis, WD, Colby, TV, Koss, MN, et al. Connective Tissue and Inflammatory Bowel Diseases. Non-Neoplastic Disorders of the Lower Respiratory Tract, 1st ed. Washington DC: American Registry of Pathology and the Armed Forces Institute of Pathology, 2002. pp. 291–320.
Tansey, D, Wells, AU, Colby, TV, et al. Variations in histological patterns of interstitial pneumonia between connective tissue disorders and their relationship to prognosis. Histopathology 2004;44(6):585–96.
Yousem, SA, Dacic, S.Pulmonary lymphohistiocytic reactions temporally related to etanercept therapy. Mod Pathol 2005;18(5):651–5.
Hagiwara, K, Sato, T, Takagi-Kobayashi, S, et al. Acute exacerbation of preexisting interstitial lung disease after administration of etanercept for rheumatoid arthritis. J Rheumatol 2007;34(5):1151–4.
Kudrin, A, Chilvers, ER, Ginawi, A, et al. Sarcoid-like granulomatous disease following etanercept treatment for RA. J Rheumatol 2007;34(3):648–9.
Saint, Marcoux B, De Bandt, M.Vasculitides induced by TNFalpha antagonists: a study in 39 patients in France. Joint Bone Spine 2006;73(6):710–3.
Villeneuve, E, St-Pierre, A, Haraoui, B.Interstitial pneumonitis associated with infliximab therapy. J Rheumatol 2006;33(6):1189–93.
Ostor, AJ, Chilvers, ER, Somerville, MF, et al. Pulmonary complications of infliximab therapy in patients with rheumatoid arthritis. J Rheumatol 2006;33(3):622–8.
Parambil, JG, Myers, JL, Lindell, RM, Matteson, EL, Ryu, JH.Interstitial lung disease in primary Sjögren syndrome. Chest 2006;130(5):1489–95.
Marenco, JL, Sanchez-Burson, J, Ruiz, Campos J, Jimenez, MD, Garcia-Bragado, F.Pulmonary amyloidosis and unusual lung involvement in SLE. Clin Rheumatol 1994;13(3):525–7.
Calatayud, J, Candelas, G, Gomez, A, Morado, C, Trancho, FH.Nodular pulmonary amyloidosis in a patient with rheumatoid arthritis. Clin Rheumatol 2007;26(10):1797–8.
Sumiya, M, Ohya, N, Shinoura, H, et al. Diffuse interstitial pulmonary amyloidosis in rheumatoid arthritis. J Rheumatol 1996;23(5):933–6.
Wong, BC, Wong, KL, Ip, MS, Wang, EP, Chan, KW, Cheng, LC.Sjögren's syndrome with amyloid A presenting as multiple pulmonary nodules. J Rheumatol 1994;21(1):165–7.
Motegi, M, Suzuki, Y, Takayanagi, N, et al. [A case of multiple nodular pulmonary amyloidosis associated with Sjögren's syndrome]. Nihon Kyobu Shikkan Gakkai Zasshi 1994;32(10):1016–21.
Kanoh, T, Suzuki, K, Kawaguchi, S.[Multifocal nodular AL amyloidosis in primary Sjögren's syndrome]. Rinsho Ketsueki 1998;39(12):1157–62.
Kobayashi, H, Matsuoka, R, Kitamura, S, Tsunoda, N, Saito, K.Sjögren's syndrome with multiple bullae and pulmonary nodular amyloidosis. Chest 1988;94(2):438–40.
Tsunoda, N, Saito, K, Kobayashi, H, Matsuoka, R, Kitamura, S.[A case of multiple nodular pulmonary amyloidosis associated with Sjögren's syndrome and multiple bullae]. Nihon Kyobu Shikkan Gakkai Zasshi 1987;25(12):1364–9.
Hosono, T, Bando, M, Suzuki, E, et al. [Sjögren's syndrome with multiple bullae due to pulmonary nodular amyloidosis]. Nihon Kokyuki Gakkai Zasshi 2007;45(11):869–73.
Fujita, J, Tokuda, M, Bandoh, S, et al. Primary lung cancer associated with polymyositis/dermatomyositis, with a review of the literature. Rheumatol Int 2001;20(2):81–4.
Zantos, D, Zhang, Y, Felson, D.The overall and temporal association of cancer with polymyositis and dermatomyositis. J Rheumatol 1994;21(10):1855–9.
Buchbinder, R, Hill, CL.Malignancy in patients with inflammatory myopathy. Curr Rheumatol Rep 2002;4(5):415–26.
Chow, WH, Gridley, G, Mellemkjaer, L, et al. Cancer risk following polymyositis and dermatomyositis: a nationwide cohort study in Denmark. Cancer Causes Control 1995;6(1):9–13.
Papiris, SA, Kalomenidis, I, Malagari, K, et al. Extranodal marginal zone B-cell lymphoma of the lung in Sjögren's syndrome patients: reappraisal of clinical, radiological, and pathology findings. Respir Med 2007;101(1):84–92.
Masaki, Y, Sugai, S.Lymphoproliferative disorders in Sjögren's syndrome. Autoimmun Rev 2004;3(3):175–82.
Hansen, LA, Prakash, UB, Colby, TV.Pulmonary lymphoma in Sjögren's syndrome. Mayo Clin Proc 1989;64(8):920–31.
Royer, B, Cazals-Hatem, D, Sibilia, J, et al. Lymphomas in patients with Sjögren's syndrome are marginal zone B-cell neoplasms, arise in diverse extranodal and nodal sites, and are not associated with viruses. Blood 1997;90(2):766–75.
Mellemkjaer, L, Linet, MS, Gridley, G, et al. Rheumatoid arthritis and cancer risk. Eur J Cancer 1996;32A(10):1753–7.
Thomas, E, Brewster, DH, Black, RJ, Macfarlane, GJ.Risk of malignancy among patients with rheumatic conditions. Int J Cancer 2000;88(3):497–502.
Thomas, E, Symmons, DP, Brewster, DH, Black, RJ, Macfarlane, GJ.National study of cause-specific mortality in rheumatoid arthritis, juvenile chronic arthritis, and other rheumatic conditions: a 20 year follow-up study. J Rheumatol 2003;30(5):958–65.
Bin, J, Bernatsky, S, Gordon, C, et al. Lung cancer in systemic lupus erythematosus. Lung Cancer 2007;56(3):303–6.
Khurana, R, Wolf, R, Berney, S, et al. Risk of development of lung cancer is increased in patients with rheumatoid arthritis: a large case control study in US veterans. J Rheumatol 2008;35(9):1704–8.
Bouros, D, Hatzakis, K, Labrakis, H, Zeibecoglou, K.Association of malignancy with diseases causing interstitial pulmonary changes. Chest 2002;121(4):1278–89.
Roumm, AD, Medsger, TA. Cancer and systemic sclerosis. An epidemiologic study. Arthritis Rheum 1985;28(12):1336–40.
Parambil, JG, Myers, JL, Ryu, JH.Diffuse alveolar damage: uncommon manifestation of pulmonary involvement in patients with connective tissue diseases. Chest 2006;130(2):553–8.
Muir, TE, Tazelaar, HD, Colby, TV, Myers, JL.Organizing diffuse alveolar damage associated with progressive systemic sclerosis. Mayo Clin Proc 1997;72(7):639–42.
Ostor, AJ, Crisp, AJ, Somerville, MF, Scott, DG.Fatal exacerbation of rheumatoid arthritis associated fibrosing alveolitis in patients given infliximab. BMJ 2004;329(7477):1266.
Tzelepis, GE, Toya, SP, Moutsopoulos, HM.Occult connective tissue diseases mimicking idiopathic interstitial pneumonias. Eur Respir J 2008;31(1):11–20.
Strange, C, Highland, KB.Interstitial lung disease in the patient who has connective tissue disease. Clin Chest Med 2004;25(3):549–59, vii.
Park, JH, Kim, DS, Park, IN, Jang, SJ, Kitaichi, M, Nicholson, AG, et al. Prognosis of fibrotic interstitial pneumonia: idiopathic versus collagen vascular disease-related subtypes. Am J Respir Crit Care Med 2007;175(7):705–11.
Cipriani, NA, Bhorade, S, Garrity, E, et al. Pieces of the puzzle: using nonspecific interstitial pneumonia (NSIP) as a clue to the diagnosis of connective tissue disease in usual interstitial pneumonia. Mod Pathol [abstract] 2009;22 (supplement 1):351A.
Agarwal, SK, Reveille, JD.The genetics of scleroderma (systemic sclerosis). Curr Opin Rheumatol 2010;22(2):133–8.
Crispin, JC, Liossis, SN, Kis-Toth, K, et al. Pathogenesis of human systemic lupus erythematosus: recent advances. Trends Mol Med 2010;16(2):47–57.
Maksymowych, WP, Brown, MA.Genetics of ankylosing spondylitis and rheumatoid arthritis: where are we at currently, and how do they compare?Clin Exp Rheumatol 2009;27(4 Suppl 55):S20–5.
Orozco, G, Barton, A.Update on the genetic risk factors for rheumatoid arthritis. Expert Rev Clin Immunol 2010;6(1):61–75.
Raychaudhuri, S.Recent advances in the genetics of rheumatoid arthritis. Curr Opin Rheumatol 2010;22(2):109–18.
Bilgici, A, Ulusoy, H, Kuru, O, et al. Pulmonary involvement in rheumatoid arthritis. Rheumatol Int 2005;25(6):429–35.
Tanoue, LT.Pulmonary manifestations of rheumatoid arthritis. Clin Chest Med 1998;19(4):667–85, viii.
Brown, KK.Rheumatoid lung disease. Proc Am Thorac Soc 2007;4(5):443–8.
Crestani, B.The respiratory system in connective tissue disorders. Allergy 2005;60(6):715–34.
Joseph, J, Sahn, SA.Connective tissue diseases and the pleura. Chest 1993;104(1):262–70.
Katzenstein, A-LA, Askin, FB.Systemic Diseases Involving the Lung. Surgical Pathology of Non-Neoplastic Lung Disease, 4th ed. Philadelphia: Elsevier Saunders, 2006. pp. 187–215.
Guinee, DG. Update on nonneoplastic pulmonary lymphoproliferative disorders and related entities. Arch Pathol Lab Med 2010;134(5):691–701.
Yousem, SA, Colby, TV, Carrington, CB.Lung biopsy in rheumatoid arthritis. Am Rev Respir Dis 1985;131(5):770–7.
Voulgari, PV, Tsifetaki, N, Metafratzi, ZM, et al. A single pulmonary rheumatoid nodule masquerading as malignancy. Clin Rheumatol 2005;24(5):556–9.
Kitamura, A, Matsuno, T, Narita, M, et al. Rheumatoid arthritis with diffuse pulmonary rheumatoid nodules. Pathol Int 2004;54(10):798–802.
Toussirot, E, Berthelot, JM, Pertuiset, E, et al. Pulmonary nodulosis and aseptic granulomatous lung disease occurring in patients with rheumatoid arthritis receiving tumor necrosis factor-alpha-blocking agent: a case series. J Rheumatol 2009;36(11):2421–7.
Baruch, AC, Steinbronn, K, Sobonya, R.Pulmonary adenocarcinomas associated with rheumatoid nodules: a case report and review of the literature. Arch Pathol Lab Med 2005;129(1):104–6.
Khazeni, N, Homer, RJ, Rubinowitz, AN, Chupp, GL.Massive cavitary pulmonary rheumatoid nodules in a patient with HIV. Eur Respir J 2006;28(4):872–4.
Robinson, C, Singh, N, Addis, B.Eosinophilic pneumonia and aspergillus colonization of rheumatoid nodules. Histopathology 2005;46(6):709–10.
McConnochie, K, O'Sullivan, M, Khalil, JF, Pritchard, MH, Gibbs, AR.Aspergillus colonization of pulmonary rheumatoid nodule. Respir Med 1989;83(2):157–60.
Caplan, A.Certain unusual radiological appearances in the chest of coal-miners suffering from rheumatoid arthritis. Thorax 1953;8(1):29–37.
Leikin, E, Zickel-Shalom, K, Balabir-Gurman, A, Goralnik, L, Valdovsky, E.[Caplan's syndrome in marble workers as occupational disease]. Harefuah 2009;148(8):524–6, 72.
Caplan, A, Cowen, ED, Gough, J.Rheumatoid pneumoconiosis in a foundry worker. Thorax 1958;13(3):181–4.
Hayes, DS, Posner, E.A case of Caplan's syndrome in a roof tile maker. Tubercle 1960;41:143–5.
Morgan, WK.Rheumatoid pneumoconiosis in association with asbestosis. Thorax 1964;19:433–5.
Helmers, R, Galvin, J, Hunninghake, GW.Pulmonary manifestations associated with rheumatoid arthritis. Chest 1991;100(1):235–8.
Lamblin, C, Bergoin, C, Saelens, T, Wallaert, B.Interstitial lung diseases in collagen vascular diseases. Eur Respir J Suppl 2001;32:69s–80s.
Gough, J, Rivers, D, Seal, RM.Pathological studies of modified pneumoconiosis in coal-miners with rheumatoid arthritis; Caplan's syndrome. Thorax 1955;10(1):9–18.
American Thoracic Society/European Respiratory Society International Multidisciplinary Consensus Classification of the Idiopathic Interstitial Pneumonias. This joint statement of the American Thoracic Society (ATS), and the European Respiratory Society (ERS) was adopted by the ATS board of directors, June 2001 and by the ERS Executive Committee, June 2001. Am J Respir Crit Care Med 2002;165(2):277–304.
Lee, HK, Kim, DS, Yoo, B, et al. Histopathologic pattern and clinical features of rheumatoid arthritis-associated interstitial lung disease. Chest 2005;127(6):2019–27.
Tanaka, N, Kim, JS, Newell, JD, et al. Rheumatoid arthritis-related lung diseases: CT findings. Radiology 2004;232(1):81–91.
Kim, EJ, Collard, HR, King, TE. Rheumatoid arthritis-associated interstitial lung disease: the relevance of histopathologic and radiographic pattern. Chest 2009;136(5):1397–405.
Yoshinouchi, T, Ohtsuki, Y, Fujita, J, et al. Nonspecific interstitial pneumonia pattern as pulmonary involvement of rheumatoid arthritis. Rheumatol Int 2005;26(2):121–5.
Flaherty, KR, Colby, TV, Travis, WD, et al. Fibroblastic foci in usual interstitial pneumonia: idiopathic versus collagen vascular disease. Am J Respir Crit Care Med 2003;167(10):1410–5.
Travis, WD, Colby, TV, Koss, MN, et al. Bronchiolar Disorders. Non-Neoplastic Disorders of the Lower Respiratory Tract, 1st ed. Washington DC: American Regristry of Pathology and the Armed Forces Institute of Pathology, 2002. pp. 351–80.
Cordier, JF.Organising pneumonia. Thorax 2000;55(4):318–28.
Mori, S, Cho, I, Koga, Y, Sugimoto, M.A simultaneous onset of organizing pneumonia and rheumatoid arthritis, along with a review of the literature. Mod Rheumatol 2008;18(1):60–6.
Liebow, AA, Carrington, CB.Diffuse pulmonary lymphoreticular infiltrations associated with dysproteinemia. Med Clin North Am 1973;57:809–43.
Strimlan, CV. Lymphocytic interstitial pneumonitis. Review of 13 cases. Ann Intern Med 1978;88:616–21.
Cha, SI, Fessler, MB, Cool, CD, Schwarz, MI, Brown, KK.Lymphoid interstitial pneumonia: clinical features, associations and prognosis. Eur Respir J 2006;28(2):364–9.
Park, IN, Kim, DS, Shim, TS, et al. Acute exacerbation of interstitial pneumonia other than idiopathic pulmonary fibrosis. Chest 2007;132(1):214–20.
White, ES, Tazelaar, HD, Lynch, JP. Bronchiolar complications of connective tissue diseases. Semin Respir Crit Care Med 2003;24(5):543–66.
Ryu, JH, Myers, JL, Swensen, SJ.Bronchiolar disorders. Am J Respir Crit Care Med 2003;168(11):1277–92.
Couture, C, Colby, TV.Histopathology of bronchiolar disorders. Semin Respir Crit Care Med 2003;24(5):489–98.
Kraft, M, Mortenson, RL, Colby, TV, et al. Cryptogenic constrictive bronchiolitis. A clinicopathologic study. Am Rev Respir Dis 1993;148(4 Pt 1):1093–101.
Visscher, DW, Myers, JL.Bronchiolitis: the pathologist's perspective. Proc Am Thorac Soc 2006;3(1):41–7.
Yokoi, T, Hirabayashi, N, Ito, M, et al. Broncho-bronchiolitis obliterans as a complication of bone marrow transplantation: a clinicopathological study of eight autopsy cases. Nagoya BMT Group. Virchows Arch 1997;431(4):275–82.
Rangel-Moreno, J, Hartson, L, Navarro, C, et al. Inducible bronchus-associated lymphoid tissue (iBALT) in patients with pulmonary complications of rheumatoid arthritis. J Clin Invest 2006;116(12):3183–94.
Yousem, SA, Colby, TV, Carrington, CB.Follicular bronchitis/bronchiolitis. Hum Pathol 1985;16(7):700–6.
Travis, WD, Galvin, JR.Non-neoplastic pulmonary lymphoid lesions. Thorax 2001;56(12):964–71.
Romero, S, Barroso, E, Gil, J, et al. Follicular bronchiolitis: clinical and pathologic findings in six patients. Lung 2003;181(6):309–19.
Aerni, MR, Vassallo, R, Myers, JL, Lindell, RM, Ryu, JH.Follicular bronchiolitis in surgical lung biopsies: clinical implications in 12 patients. Respir Med 2008;102(2):307–12.
Kitasato, Y, Nagata, N, Ikedou, Y, et al. [A case of follicular bronchiolitis preceding rheumatoid arthritis]. Nihon Kokyuki Gakkai Zasshi 2006;44(2):104–10.
Howling, SJ, Hansell, DM, Wells, AU, et al. Follicular bronchiolitis: thin-section CT and histologic findings. Radiology 1999;212(3):637–42.
Hayakawa, H, Sato, A, Imokawa, S, et al. Bronchiolar disease in rheumatoid arthritis. Am J Respir Crit Care Med 1996;154(5):1531–6.
Matsui, S, Yamashita, N, Narukawa, M, et al. [Rheumatoid arthritis-associated bronchiolitis successfully treated with erythromycin]. Nihon Kokyuki Gakkai Zasshi 2000;38(3):195–200.
Homma, S, Kawabata, M, Kishi, K, Tsuboi, E, Narui, K, Nakatani, T, et al. Diffuse panbronchiolitis in rheumatoid arthritis. Eur Respir J 1998;12(2):444–52.
McDonagh, J, Greaves, M, Wright, AR, et al. High resolution computed tomography of the lungs in patients with rheumatoid arthritis and interstitial lung disease. Br J Rheumatol 1994;33(2):118–22.
Remy-Jardin, M, Remy, J, Cortet, B, Mauri, F, Delcambre, B.Lung changes in rheumatoid arthritis: CT findings. Radiology 1994;193(2):375–82.
Swinson, DR, Symmons, D, Suresh, U, Jones, M, Booth, J.Decreased survival in patients with co-existent rheumatoid arthritis and bronchiectasis. Br J Rheumatol 1997;36(6):689–91.
Hassoun, PM.Pulmonary arterial hypertension complicating connective tissue diseases. Semin Respir Crit Care Med 2009;30(4):429–39.
Asherson, RA, Morgan, SH, Hackett, D, et al. Rheumatoid arthritis and pulmonary hypertension. A report of three cases. J Rheumatol 1985;12(1):154–9.
Morikawa, J, Kitamura, K, Habuchi, Y, et al. Pulmonary hypertension in a patient with rheumatoid arthritis. Chest 1988;93(4):876–8.
Schwarz, MI, Zamora, MR, Hodges, TN, Chan, ED, Bowler, RP, Tuder, RM.Isolated pulmonary capillaritis and diffuse alveolar hemorrhage in rheumatoid arthritis and mixed connective tissue disease. Chest 1998;113(6):1609–15.
Travis, WD, Colby, TV, Lombard, C, Carpenter, HA.A clinicopathologic study of 34 cases of diffuse pulmonary hemorrhage with lung biopsy confirmation. Am J Surg Pathol 1990;14(12):1112–25.
Armstrong, JG, Steele, RH.Localised pulmonary arteritis in rheumatoid disease. Thorax 1982;37(4):313–4.
Torralbo, A, Herrero, JA, Portoles, J, Barrientos, A.Alveolar hemorrhage associated with antineutrophil cytoplasmic antibodies in rheumatoid arthritis. Chest 1994;105(5):1590–2.
Naschitz, JE, Yeshurun, D, Scharf, Y, et al. Recurrent massive alveolar hemorrhage, crescentic glomerulonephritis, and necrotizing vasculitis in a patient with rheumatoid arthritis. Arch Intern Med 1989;149(2):406–8.
Lemley, DE, Katz, P.Rheumatoid-like arthritis presenting as idiopathic pulmonary hemosiderosis: a report and review of the literature. J Rheumatol 1986;13(5):954–7.
Mori, S, Koga, Y, Imamura, F, Cho, I, Sugimoto, M.Early rheumatoid arthritis in a patient with Sjögren's syndrome and pulmonary nodular amyloidosis: clinical implication of early limited use of infliximab. Mod Rheumatol 2007;17(6):500–6.
Norman, D, Piecyk, M, Roberts, DH.Eosinophilic pneumonia as an initial manifestation of rheumatoid arthritis. Chest 2004;126(3):993–5.
Papiris, SA, Maniati, MA, Kalousis, JV, Constantopoulos, SH.Chronic eosinophilic pneumonia in rheumatoid arthritis. Monaldi Arch Chest Dis 1995;50(5):360–2.
Mehandru, S, Smith, RL, Sidhu, GS, Cassai, N, Aranda, CP.Migratory pulmonary infiltrates in a patient with rheumatoid arthritis. Thorax 2002;57(5):465–7.
Cooney, TP.Interrelationship of chronic eosinophilic pneumonia, bronchiolitis obliterans, and rheumatoid disease: a hypothesis. J Clin Pathol 1981;34(2):129–37.
Strohl, KP, Feldman, NT, Ingram, RH. Apical fibrobullous disease with rheumatoid arthritis. Chest 1979;75(6):739–41.
Yue, CC, Park, CH, Kushner, I.Apical fibrocavitary lesions of the lung in rheumatoid arthritis. Report of two cases and review of the literature. Am J Med 1986;81(4):741–6.
Hoshida, Y, Xu, JX, Fujita, S, et al. Lymphoproliferative disorders in rheumatoid arthritis: clinicopathological analysis of 76 cases in relation to methotrexate medication. J Rheumatol 2007;34(2):322–31.
Salloum, E, Cooper, DL, Howe, G, et al. Spontaneous regression of lymphoproliferative disorders in patients treated with methotrexate for rheumatoid arthritis and other rheumatic diseases. J Clin Oncol 1996;14(6):1943–9.
Hunninghake, GW, Fauci, AS.Pulmonary involvement in the collagen vascular diseases. Am Rev Respir Dis 1979;119(3):471–503.
Haupt, HM, Moore, GW, Hutchins, GM.The lung in systemic lupus erythematosus. Analysis of the pathologic changes in 120 patients. Am J Med 1981;71(5):791–8.
Quadrelli, SA, Alvarez, C, Arce, SC, et al. Pulmonary involvement of systemic lupus erythematosus: analysis of 90 necropsies. Lupus 2009;18(12):1053–60.
Miller, LR, Greenberg, SD, McLarty, JW.Lupus lung. Chest 1985;88(2):265–9.
Fayemi, AO.The lung in systemic lupus erythematosus: a clinico-pathologic study of 20 cases. Mt Sinai J Med 1975;42(2):110–8.
Zamora, MR, Warner, ML, Tuder, R, Schwarz, MI.Diffuse alveolar hemorrhage and systemic lupus erythematosus. Clinical presentation, histology, survival, and outcome. Medicine (Baltimore) 1997;76(3):192–202.
Carette, S, Macher, AM, Nussbaum, A, Plotz, PH.Severe, acute pulmonary disease in patients with systemic lupus erythematosus: ten years of experience at the National Institutes of Health. Semin Arthritis Rheum 1984;14(1):52–9.
Specks, U.Diffuse alveolar hemorrhage syndromes. Curr Opin Rheumatol 2001;13(1):12–7.
Hughson, MD, He, Z, Henegar, J, McMurray, R.Alveolar hemorrhage and renal microangiopathy in systemic lupus erythematosus. Arch Pathol Lab Med 2001;125(4):475–83.
Lee, JG, Joo, KW, Chung, WK, et al. Diffuse alveolar hemorrhage in lupus nephritis. Clin Nephrol 2001;55(4):282–8.
Byrd, RB, Trunk, G.Systemic lupus erythematosus presenting as pulmonary hemosiderosis. Chest 1973;64(1):128–9.
Myers, JL, Katzenstein, AA.Microangiitis in lupus-induced pulmonary hemorrhage. Am J Clin Pathol 1986;85(5):552–6.
Franks, TJ, Koss, MN.Pulmonary capillaritis. Curr Opin Pulm Med 2000;6(5):430–5.
Mark, EJ, Ramirez, JF.Pulmonary capillaritis and hemorrhage in patients with systemic vasculitis. Arch Pathol Lab Med 1985;109(5):413–8.
Gertner, E.Diffuse alveolar hemorrhage in the antiphospholipid syndrome: spectrum of disease and treatment. J Rheumatol 1999;26(4):805–7.
Crausman, RS, Achenbach, GA, Pluss, WT, O'Brien, RF, Jennings, CA.Pulmonary capillaritis and alveolar hemorrhage associated with the antiphospholipid antibody syndrome. J Rheumatol 1995;22(3):554–6.
Zachee, P, Vermylen, J, Boogaerts, MA.Hematologic aspects of end-stage renal failure. Ann Hematol 1994;69(1):33–40.
Kwong, YL, Wong, KL, Kung, IT, Chan, PC, Lam, WK.Concomitant alveolar haemorrhage and cytomegalovirus infection in a patient with systemic lupus erythematosus. Postgrad Med J 1988;64(747):56–9.
Holt, P.Systemic vasculitis associated with long-term phenytoin therapy. N Z Med J 1999;112(1084):100.
Nicolls, MR, Terada, LS, Tuder, RM, Prindiville, SA, Schwarz, MI.Diffuse alveolar hemorrhage with underlying pulmonary capillaritis in the retinoic acid syndrome. Am J Respir Crit Care Med 1998;158(4):1302–5.
Ohtsuka, M, Yamashita, Y, Doi, M, Hasegawa, S.Propylthiouracil-induced alveolar haemorrhage associated with antineutrophil cytoplasmic antibody. Eur Respir J 1997;10(6):1405–7.
Dhillon, SS, Singh, D, Doe, N, et al. Diffuse alveolar hemorrhage and pulmonary capillaritis due to propylthiouracil. Chest 1999;116(5):1485–8.
Choi, HK, Merkel, PA, Walker, AM, Niles, JL.Drug-associated antineutrophil cytoplasmic antibody-positive vasculitis: prevalence among patients with high titers of antimyeloperoxidase antibodies. Arthritis Rheum 2000;43(2):405–13.
Schwarz, MI, Sutarik, JM, Nick, JA, et al. Pulmonary capillaritis and diffuse alveolar hemorrhage. A primary manifestation of polymyositis. Am J Respir Crit Care Med 1995;151(6):2037–40.
Horiki, T, Fuyuno, G, Ishii, M, et al. Fatal alveolar hemorrhage in a patient with mixed connective tissue disease presenting polymyositis features. Intern Med 1998;37(6):554–60.
Chaer, RA, Massad, MG, Evans, A, Olopade, C, Varga, J.Systemic sclerosis complicated by diffuse alveolar hemorrhage. Med Sci Monit 2001 Sep-Oct;7(5):1013–5.
Churg, A, Franklin, W, Chan, KL, Kopp, E, Carrington, CB.Pulmonary hemorrhage and immune-complex deposition in the lung. Complications in a patient with systemic lupus erythematosus. Arch Pathol Lab Med 1980;104(7):388–91.
Rodriguez-Iturbe, B, Garcia, R, Rubio, L, Serrano, H.Immunohistologic findings in the lung in systemic lupus erythematosus. Arch Pathol Lab Med 1977;101(7):342–4.
Matthay, RA, Schwarz, MI, Petty, TL, et al. Pulmonary manifestations of systemic lupus erythematosus: review of twelve cases of acute lupus pneumonitis. Medicine (Baltimore) 1975;54(5):397–409.
Badui, E, Garcia-Rubi, D, Robles, E, et al. Cardiovascular manifestations in systemic lupus erythematosus. Prospective study of 100 patients. Angiology 1985;36(7):431–41.
Simonson, JS, Schiller, NB, Petri, M, Hellmann, DB.Pulmonary hypertension in systemic lupus erythematosus. J Rheumatol 1989;16(7):918–25.
Perez, HD, Kramer, N.Pulmonary hypertension in systemic lupus erythematosus: report of four cases and review of the literature. Semin Arthritis Rheum 1981;11(1):177–81.
Fayemi, AO.Pulmonary vascular disease in systemic lupus erythematosus. Am J Clin Pathol 1976;65(3):284–90.
Case records of the Massachusetts General Hospital. Weekly clinicopathological exercises. Case 4–1973. N Engl J Med 1973;288(4):204–10.
Nair, SS, Askari, AD, Popelka, CG, Kleinerman, JF.Pulmonary hypertension and systemic lupus erythematosus. Arch Intern Med 1980;140(1):109–11.
Quismorio, FP, Sharma, O, Koss, M, et al. Immunopathologic and clinical studies in pulmonary hypertension associated with systemic lupus erythematosus. Semin Arthritis Rheum 1984;13(4):349–59.
Yokoi, T, Tomita, Y, Fukaya, M, et al. Pulmonary hypertension associated with systemic lupus erythematosus: predominantly thrombotic arteriopathy accompanied by plexiform lesions. Arch Pathol Lab Med 1998;122(5):467–70.
De Clerck, LS, Michielsen, PP, Ramael, MR, et al. Portal and pulmonary vessel thrombosis associated with systemic lupus erythematosus and anticardiolipin antibodies. J Rheumatol 1991;18(12):1919–21.
Vianna, JL, Khamashta, MA, Ordi-Ros, J, et al. Comparison of the primary and secondary antiphospholipid syndrome: a European Multicenter Study of 114 patients. Am J Med 1994;96(1):3–9.
Asherson, RA, Cervera, R.Pulmonary hypertension, antiphospholipid antibodies, and syndromes. Clin Rev Allergy Immunol 2007;32(2):153–8.
Espinosa, G, Cervera, R, Font, J, Asherson, RA.The lung in the antiphospholipid syndrome. Ann Rheum Dis 2002;61(3):195–8.
Stojanovich, L.Pulmonary manifestations in antiphospholipid syndrome. Autoimmun Rev 2006;5(5):344–8.
Brucato, A, Baudo, F, Barberis, M, et al. Pulmonary hypertension secondary to thrombosis of the pulmonary vessels in a patient with the primary antiphospholipid syndrome. J Rheumatol 1994;21(5):942–4.
Asherson, RA, Cervera, R.Review: antiphospholipid antibodies and the lung. J Rheumatol 1995;22(1):62–6.
Yutani, C, Imakita, M, Ishibashi-Ueda, H, et al. Pulmonary thromboembolic hypertension in systemic lupus erythematosus with lupus anticoagulant: histopathological analysis of localization and distribution of thromboemboli in pulmonary vasculature. Intern Med 1995;34(10):1030–4.
Asherson, RA, Mackworth-Young, CG, Boey, ML, et al. Pulmonary hypertension in systemic lupus erythematosus. Br Med J (Clin Res Ed) 1983;287(6398):1024–5.
Kishida, Y, Kanai, Y, Kuramochi, S, Hosoda, Y.Pulmonary venoocclusive disease in a patient with systemic lupus erythematosus. J Rheumatol 1993;20(12):2161–2.
Fernandez-Alonso, J, Zulueta, T, Reyes-Ramirez, JR, Castillo-Palma, MJ, Sanchez-Roman, J.Pulmonary capillary hemangiomatosis as cause of pulmonary hypertension in a young woman with systemic lupus erythematosus. J Rheumatol 1999;26(1):231–3.
Dorfmuller, P, Humbert, M, Perros, F, et al. Fibrous remodeling of the pulmonary venous system in pulmonary arterial hypertension associated with connective tissue diseases. Hum Pathol 2007;38(6):893–902.
Yoshio, T, Masuyama, J, Sumiya, M, Minota, S, Kano, S.Antiendothelial cell antibodies and their relation to pulmonary hypertension in systemic lupus erythematosus. J Rheumatol 1994;21(11):2058–63.
Orens, JB, Martinez, FJ, Lynch, JP. Pleuropulmonary manifestations of systemic lupus erythematosus. Rheum Dis Clin North Am 1994;20(1):159–93.
Goupille, P, Fauchier, L, Babuty, D, Fauchier, JP, Valat, JP.Precapillary pulmonary hypertension dramatically improved with high doses of corticosteroids during systemic lupus erythematosus. J Rheumatol 1994;21(10):1976–7.
Jacobsen, S, Petersen, J, Ullman, S, et al. A multicentre study of 513 Danish patients with systemic lupus erythematosus. II. Disease mortality and clinical factors of prognostic value. Clin Rheumatol 1998;17(6):478–84.
Jacobsen, S, Petersen, J, Ullman, S, et al. A multicentre study of 513 Danish patients with systemic lupus erythematosus. I. Disease manifestations and analyses of clinical subsets. Clin Rheumatol 1998;17(6):468–77.
Weinrib, L, Sharma, OP, Quismorio, FP. A long-term study of interstitial lung disease in systemic lupus erythematosus. Semin Arthritis Rheum 1990;20(1):48–56.
Boulware, DW, Hedgpeth, MT.Lupus pneumonitis and anti-SSA(Ro) antibodies. J Rheumatol 1989;16(4):479–81.
Eisenberg, H, Dubois, EL, Sherwin, RP, Balchum, OJ.Diffuse interstitial lung disease in systemic lupus erythematosus. Ann Intern Med 1973;79(1):37–45.
Cheema, GS, Quismorio, FP. Interstitial lung disease in systemic lupus erythematosus. Curr Opin Pulm Med 2000;6(5):424–9.
Kim, EA, Lee, KS, Johkoh, T, et al. Interstitial lung diseases associated with collagen vascular diseases: radiologic and histopathologic findings. Radiographics 2002;22 Spec No:S151–65.
Filipek, MS, Thompson, ME, Wang, PL, Gosselin, MV, Primack, S.Lymphocytic interstitial pneumonitis in a patient with systemic lupus erythematosus: radiographic and high-resolution CT findings. J Thorac Imaging 2004;19(3):200–3.
Yood, RA, Steigman, DM, Gill, LR.Lymphocytic interstitial pneumonitis in a patient with systemic lupus erythematosus. Lupus 1995;4(2):161–3.
Gammon, RB, Bridges, TA, al-Nezir, H, Alexander, CB, Kennedy, JI. Bronchiolitis obliterans organizing pneumonia associated with systemic lupus erythematosus. Chest 1992;102(4):1171–4.
Min, JK, Hong, YS, Park, SH, et al. Bronchiolitis obliterans organizing pneumonia as an initial manifestation in patients with systemic lupus erythematosus. J Rheumatol 1997;24(11):2254–7.
Nakamura, K, Akizuki, M, Ichikawa, Y, Mukai, M, Satoh, M.[Occurrence of bronchiolitis obliterans organizing pneumonia (BOOP) in a flare-up stage of systemic lupus erythematosus (SLE)]. Ryumachi 1993;33(2):156–61.
Warrington, KJ, Moder, KG, Brutinel, WM.The shrinking lungs syndrome in systemic lupus erythematosus. Mayo Clin Proc 2000;75(5):467–72.
Ellman, P, Cudkowicz, L.Pulmonary manifestations in the diffuse collagen diseases. Thorax 1954;9(1):46–57.
Tumulty, PA.The clinical course of systemic lupus erythematosus. J Am Med Assoc 1954;156(10):947–53.
Harvey, AM, Shulman, LE, Tumulty, PA, Conley, CL, Schoenrich, EH.Systemic lupus erythematosus: review of the literature and clinical analysis of 138 cases. Medicine (Baltimore) 1954;33(4):291–437.
Rubin, LA, Urowitz, MB.Shrinking lung syndrome in SLE – a clinical pathologic study. J Rheumatol 1983;10(6):973–6.
Thompson, PJ, Dhillon, DP, Ledingham, J, Turner-Warwick, M.Shrinking lungs, diaphragmatic dysfunction, and systemic lupus erythematosus. Am Rev Respir Dis 1985;132(4):926–8.
Martens, J, Demedts, M, Vanmeenen, MT, Dequeker, J.Respiratory muscle dysfunction in systemic lupus erythematosus. Chest 1983;84(2):170–5.
Al-Raqum, HA, Uppal, SS, Al-Mutairy, M, Kumari, R.Shrinking lung syndrome as a presenting manifestation of systemic lupus erythematosus in a female Kuwaiti. Clin Rheumatol 2006;25(3):412–4.
Hardy, K, Herry, I, Attali, V, Cadranel, J, Similowski, T.Bilateral phrenic paralysis in a patient with systemic lupus erythematosus. Chest 2001;119(4):1274–7.
Laroche, CM, Mulvey, DA, Hawkins, PN, Walport, MJ, Strickland, B, Moxham, J, et al. Diaphragm strength in the shrinking lung syndrome of systemic lupus erythematosus. Q J Med 1989;71(265):429–39.
Walz-Leblanc, BA, Urowitz, MB, Gladman, DD, Hanly, PJ.The “shrinking lungs syndrome” in systemic lupus erythematosus – improvement with corticosteroid therapy. J Rheumatol 1992;19(12):1970–2.
Kim, JS, Lee, KS, Koh, EM, et al. Thoracic involvement of systemic lupus erythematosus: clinical, pathologic, and radiologic findings. J Comput Assist Tomogr 2000 Jan-Feb;24(1):9–18.
Benham, H, Garske, L, Vecchio, P, Eckert, BW.Successful treatment of shrinking lung syndrome with rituximab in a patient with systemic lupus erythematosus. J Clin Rheumatol 2010;16(2):68–70.
Birnbaum, B, Sidhu, GS, Smith, RL, Pillinger, MH, Tagoe, CE.Fulminating hydralazine-induced lupus pneumonitis. Arthritis Rheum 2006;55(3):501–6.
Goldberg, SK, Lipschutz, JB, Ricketts, RM, Fein, AM.Procainamide-induced lupus lung disease characterized by neutrophil alveolitis. Am J Med 1984;76(1):146–50.
Milesi-Lecat, AM, Schmidt, J, Aumaitre, O, et al. Lupus and pulmonary nodules consistent with bronchiolitis obliterans organizing pneumonia induced by carbamazepine. Mayo Clin Proc 1997;72(12):1145–7.
Bowie, EJ, Thompson, JH, Pascuzzi, CA, Owen, CA. Thrombosis in systemic lupus erythematosus despite circulating anticoagulants. J Lab Clin Med 1963;62:416–30.
Wilson, WA, Gharavi, AE, Koike, T, et al. International consensus statement on preliminary classification criteria for definite antiphospholipid syndrome: report of an international workshop. Arthritis Rheum 1999;42(7):1309–11.
Daugas, E, Nochy, D, Huong, DL, et al. Antiphospholipid syndrome nephropathy in systemic lupus erythematosus. J Am Soc Nephrol 2002;13(1):42–52.
Hughes, GR.The antiphospholipid syndrome: ten years on. Lancet 1993;342(8867):341–4.
Galli, M, Barbui, T.Antiphospholipid syndrome: clinical and diagnostic utility of laboratory tests. Semin Thromb Hemost 2005;31(1):17–24.
Kerr, JE, Poe, R, Kramer, Z.Antiphospholipid antibody syndrome presenting as a refractory noninflammatory pulmonary vasculopathy. Chest 1997;112(6):1707–10.
Bucciarelli, S, Espinosa, G, Asherson, RA, et al. The acute respiratory distress syndrome in catastrophic antiphospholipid syndrome: analysis of a series of 47 patients. Ann Rheum Dis 2006;65(1):81–6.
Kelion, AD, Cockcroft, JR, Ritter, JM.Antiphospholipid syndrome in a patient with rapidly progressive fibrosing alveolitis. Postgrad Med J 1995;71(834):233–5.
Asherson, RA.The catastrophic antiphospholipid syndrome. J Rheumatol 1992;19(4):508–12.
Asherson, RA, Cervera, R, Piette, JC, et al. Catastrophic antiphospholipid syndrome. Clinical and laboratory features of 50 patients. Medicine (Baltimore) 1998;77(3):195–207.
Lawrence, RC, Hochberg, MC, Kelsey, JL, et al. Estimates of the prevalence of selected arthritic and musculoskeletal diseases in the United States. J Rheumatol 1989;16(4):427–41.
Carr, RD, Heisel, EB, Stevenson, TD.CRST syndrome. A benign variant of scleroderma. Arch Dermatol 1965;92(5):519–25.
Schimke, RN, Kirkpatrick, CH, Delp, MH.Calcinosis, Raynaud's phenomenon, sclerodactyly, and telangiectasia. The CRST syndrome. Arch Intern Med 1967;119(4):365–70.
Steen, VD, Medsger, TA. Severe organ involvement in systemic sclerosis with diffuse scleroderma. Arthritis Rheum 2000;43(11):2437–44.
Ferri, C, Valentini, G, Cozzi, F, et al. Systemic sclerosis: demographic, clinical, and serologic features and survival in 1,012 Italian patients. Medicine (Baltimore) 2002;81(2):139–53.
Le Pavec, J, Launay, D, Mathai, SC, Hassoun, PM, Humbert, M.Scleroderma lung disease. Clin Rev Allergy Immunol 2011;40:104–16.
Renzoni, EA.Interstitial lung disease in systemic sclerosis. Monaldi Arch Chest Dis 2007;67(4):217–28.
D'Angelo, WA, Fries, JF, Masi, AT, Shulman, LE.Pathologic observations in systemic sclerosis (scleroderma). A study of fifty-eight autopsy cases and fifty-eight matched controls. Am J Med 1969;46(3):428–40.
Yousem, SA.The pulmonary pathologic manifestations of the CREST syndrome. Hum Pathol 1990;21(5):467–74.
Bridges, AJ, Hsu, KC, Dias-Arias, AA, Chechani, V.Bronchiolitis obliterans organizing pneumonia and scleroderma. J Rheumatol 1992;19(7):1136–40.
Tanoue, LT.Pulmonary hypertension in the collagen vascular diseases. Semin Respir Crit Care Med 2003;24(3):287–96.
Harrison, NK, Myers, AR, Corrin, B, et al. Structural features of interstitial lung disease in systemic sclerosis. Am Rev Respir Dis 1991;144(3 Pt 1):706–13.
Kim, DS, Yoo, B, Lee, JS, et al. The major histopathologic pattern of pulmonary fibrosis in scleroderma is nonspecific interstitial pneumonia. Sarcoidosis Vasc Diffuse Lung Dis 2002;19(2):121–7.
Bouros, D, Wells, AU, Nicholson, AG, Colby, TV, Polychronopoulos, V, Pantelidis, P, et al. Histopathologic subsets of fibrosing alveolitis in patients with systemic sclerosis and their relationship to outcome. Am J Respir Crit Care Med 2002;165(12):1581–6.
Desai, SR, Veeraraghavan, S, Hansell, DM, et al. CT features of lung disease in patients with systemic sclerosis: comparison with idiopathic pulmonary fibrosis and nonspecific interstitial pneumonia. Radiology 2004;232(2):560–7.
Highland, KB, Silver, RM.Clinical aspects of lung involvement: lessons from idiopathic pulmonary fibrosis and the scleroderma lung study. Curr Rheumatol Rep 2005;7(2):135–41.
Nakamura, Y, Chida, K, Suda, T, et al. Nonspecific interstitial pneumonia in collagen vascular diseases: comparison of the clinical characteristics and prognostic significance with usual interstitial pneumonia. Sarcoidosis Vasc Diffuse Lung Dis 2003;20(3):235–41.
Tashkin, DP, Elashoff, R, Clements, PJ, et al. Effects of 1-year treatment with cyclophosphamide on outcomes at 2 years in scleroderma lung disease. Am J Respir Crit Care Med 2007;176(10):1026–34.
Colby, TV.Pulmonary pathology in patients with systemic autoimmune diseases. Clin Chest Med 1998;19(4):587–612, vii.
Cool, CD, Kennedy, D, Voelkel, NF, Tuder, RM.Pathogenesis and evolution of plexiform lesions in pulmonary hypertension associated with scleroderma and human immunodeficiency virus infection. Hum Pathol 1997;28(4):434–42.
Morassut, PA, Walley, VM, Smith, CD.Pulmonary veno-occlusive disease and the CREST variant of scleroderma. Can J Cardiol 1992;8(10):1055–8.
Kassan, SS, Moutsopoulos, HM.Clinical manifestations and early diagnosis of Sjögren syndrome. Arch Intern Med 2004;164(12):1275–84.
Hansen, A, Lipsky, PE, Dorner, T.New concepts in the pathogenesis of Sjögren syndrome: many questions, fewer answers. Curr Opin Rheumatol 2003;15(5):563–70.
Fischer, A, Swigris, JJ, du Bois, RM, Groshong, SD, Cool, CD, Sahin, H, et al. Minor salivary gland biopsy to detect primary Sjögren syndrome in patients with interstitial lung disease. Chest 2009;136(4):1072–8.
Garcia-Carrasco, M, Ramos-Casals, M, Rosas, J, et al. Primary Sjögren syndrome: clinical and immunologic disease patterns in a cohort of 400 patients. Medicine (Baltimore) 2002;81(4):270–80.
Deheinzelin, D, Capelozzi, VL, Kairalla, RA, et al. Interstitial lung disease in primary Sjögren's syndrome. Clinical-pathological evaluation and response to treatment. Am J Respir Crit Care Med 1996;154(3 Pt 1):794–9.
Gardiner, P, Ward, C, Allison, A, et al. Pleuropulmonary abnormalities in primary Sjögren's syndrome. J Rheumatol 1993;20(5):831–7.
Cain, HC, Noble, PW, Matthay, RA.Pulmonary manifestations of Sjögren's syndrome. Clin Chest Med 1998;19(4):687–99, viii.
Davidson, BK, Kelly, CA, Griffiths, ID.Ten year follow up of pulmonary function in patients with primary Sjögren's syndrome. Ann Rheum Dis 2000;59(9):709–12.
Katzenstein, AL, Fiorelli, RF.Nonspecific interstitial pneumonia/fibrosis. Histologic features and clinical significance. Am J Surg Pathol 1994;18(2):136–47.
Yamadori, I, Fujita, J, Bandoh, S, et al. Nonspecific interstitial pneumonia as pulmonary involvement of primary Sjögren's syndrome. Rheumatol Int 2002;22(3):89–92.
Ito, I, Nagai, S, Kitaichi, M, et al. Pulmonary manifestations of primary Sjögren's syndrome: a clinical, radiologic, and pathologic study. Am J Respir Crit Care Med 2005;171(6):632–8.
Travis, WD, Fox, CH, Devaney, KO, et al. Lymphoid pneumonitis in 50 adult patients infected with the human immunodeficiency virus: lymphocytic interstitial pneumonitis versus nonspecific interstitial pneumonitis. Hum Pathol 1992;23:529–41.
Andiman, WA, Eastman, R, Martin, K, et al. Opportunistic lymphoproliferations associated with Epstein-Barr viral DNA in infants and children with AIDS. Lancet 1985 1985;2:1390–3.
Kohler, PF, Cook, RD, Brown, WR, Manguso, RL.Common variable hypogammaglobulinemia with T-cell nodular lymphoid interstitial pneumonitis and B-cell nodular lymphoid hyperplasia: different lymphocyte populations with a similar response to prednisone therapy. J Allergy Clin Immunol 1982;70(4):299–305.
Swigris, JJ, Berry, GJ, Raffin, TA, Kuschner, WG.Lymphoid interstitial pneumonia: a narrative review. Chest 2002;122(6):2150–64.
Johkoh, T, Muller, NL, Pickford, HA, et al. Lymphocytic interstitial pneumonia: thin-section CT findings in 22 patients. Radiology 1999;212(2):567–72.
Silva, CI, Flint, JD, Levy, RD, Muller, NL.Diffuse lung cysts in lymphoid interstitial pneumonia: high-resolution CT and pathologic findings. J Thorac Imaging 2006;21(3):241–4.
Tokuyasu, H, Watanabe, E, Okazaki, R, et al. Sjögren's syndrome with multiple bullae caused by lymphocytic interstitial pneumonia. Lung 2007;185(3):187–8.
Koss, MN, Hochholzer, L, Langloss, JM, Wehunt, WD, Lazarus, AA.Lymphoid interstitial pneumonia: clinicopathological and immunopathological findings in 18 cases. Pathology 1987;19:178–85.
Fishback, N, Koss, M.Update on lymphoid interstitial pneumonitis. Curr Opin Pulm Med 1996;2(5):429–33.
Nicholson, AG.Reactive pulmonary lymphoid disorders. Histopathology 1995;26:405–12.
Katzenstein, A-LA, Askin, FB.Primary Lymphoid Lung Lesions. Surgical Pathology of Non-neoplastic Lung Disease. 4th ed. Philadelphia: Elsevier Saunders, 2006. p. 237–60.
Matteson, EL, Ike, RW.Bronchiolitis obliterans organizing pneumonia and Sjögren's syndrome. J Rheumatol 1990;17(5):676–9.
Papiris, SA, Maniati, M, Constantopoulos, SH, et al. Lung involvement in primary Sjögren's syndrome is mainly related to the small airway disease. Ann Rheum Dis 1999;58(1):61–4.
Bariffi, F, Pesci, A, Bertorelli, G, Manganelli, P, Ambanelli, U.Pulmonary involvement in Sjögren's syndrome. Respiration 1984;46(1):82–7.
Papiris, SA, Saetta, M, Turato, G, et al. CD4-positive T-lymphocytes infiltrate the bronchial mucosa of patients with Sjögren's syndrome. Am J Respir Crit Care Med 1997;156(2 Pt 1):637–41.
Andoh, Y, Shimura, S, Sawai, T, Sasaki, H, Takishima, T, Shirato, K.Morphometric analysis of airways in Sjögren's syndrome. Am Rev Respir Dis 1993;148(5):1358–62.
Constantopoulos, SH, Papadimitriou, CS, Moutsopoulos, HM.Respiratory manifestations in primary Sjögren's syndrome. A clinical, functional, and histologic study. Chest 1985;88(2):226–9.
Newball, HH, Brahim, SA.Chronic obstructive airway disease in patients with Sjögren's syndrome. Am Rev Respir Dis 1977;115(2):295–304.
Chen, HA, Lai, SL, Kwang, WK, et al. Middle lobe syndrome as the pulmonary manifestation of primary Sjögren's syndrome. Med J Aust 2006;184(6):294–5.
Launay, D, Hachulla, E, Hatron, PY, et al. Pulmonary arterial hypertension: a rare complication of primary Sjögren syndrome: report of 9 new cases and review of the literature. Medicine (Baltimore) 2007;86(5):299–315.
Sato, T, Matsubara, O, Tanaka, Y, Kasuga, T.Association of Sjögren's syndrome with pulmonary hypertension: report of two cases and review of the literature. Hum Pathol 1993;24(2):199–205.
Nakagawa, N, Osanai, S, Ide, H, et al. Severe pulmonary hypertension associated with primary Sjögren's syndrome. Intern Med 2003;42(12):1248–52.
Nakamura, N, Yamada, G, Itoh, T, et al. Pulmonary MALT lymphoma with amyloid production in a patient with primary Sjögren's syndrome. Intern Med 2002;41(4):309–11.
Song, MK, Seol, YM, Park, YE, et al. Pulmonary nodular lymphoid hyperplasia associated with Sjögren's syndrome. Korean J Intern Med 2007;22(3):192–6.
Abbondanzo, SL, Rush, W, Bijwaard, KE, Koss, MN.Nodular lymphoid hyperplasia of the lung: a clinicopathologic study of 14 cases. Am J Surg Pathol 2000;24(4):587–97.
Fathi, M, Lundberg, IE, Tornling, G.Pulmonary complications of polymyositis and dermatomyositis. Semin Respir Crit Care Med 2007;28(4):451–8.
Dalakas, MC.Polymyositis, dermatomyositis and inclusion-body myositis. N Engl J Med 1991;325(21):1487–98.
Selva-O'Callaghan, A, Labrador-Horrillo, M, Munoz-Gall, X, et al. Polymyositis/dermatomyositis-associated lung disease: analysis of a series of 81 patients. Lupus 2005;14(7):534–42.
Euwer, RL, Sontheimer, RD.Amyopathic dermatomyositis: a review. J Invest Dermatol 1993;100(1):124S–7S.
Euwer, RL, Sontheimer, RD.Amyopathic dermatomyositis (dermatomyositis sine myositis). Presentation of six new cases and review of the literature. J Am Acad Dermatol 1991;24(6 Pt 1):959–66.
Fujisawa, T, Suda, T, Nakamura, Y, et al. Differences in clinical features and prognosis of interstitial lung diseases between polymyositis and dermatomyositis. J Rheumatol 2005;32(1):58–64.
Hayashi, S, Tanaka, M, Kobayashi, H, et al. High-resolution computed tomography characterization of interstitial lung diseases in polymyositis/dermatomyositis. J Rheumatol 2008;35(2):260–9.
Dalakas, MC, Sivakumar, K.The immunopathologic and inflammatory differences between dermatomyositis, polymyositis and sporadic inclusion body myositis. Curr Opin Neurol 1996;9(3):235–9.
Hilton-Jones, D.Inflammatory muscle diseases. Curr Opin Neurol 2001;14(5):591–6.
Cottin, V, Thivolet-Bejui, F, Reynaud-Gaubert, M, et al. Interstitial lung disease in amyopathic dermatomyositis, dermatomyositis and polymyositis. Eur Respir J 2003;22(2):245–50.
Hsue, YT, Paulus, HE, Coulson, WF.Bronchiolitis obliterans organizing pneumonia in polymyositis. A case report with longterm survival. J Rheumatol 1993;20(5):877–9.
Marie, I, Hachulla, E, Cherin, P, et al. Interstitial lung disease in polymyositis and dermatomyositis. Arthritis Rheum 2002;47(6):614–22.
Tazelaar, HD, Viggiano, RW, Pickersgill, J, Colby, TV.Interstitial lung disease in polymyositis and dermatomyositis. Clinical features and prognosis as correlated with histologic findings. Am Rev Respir Dis 1990;141(3):727–33.
Douglas, WW, Tazelaar, HD, Hartman, TE, et al. Polymyositis-dermatomyositis-associated interstitial lung disease. Am J Respir Crit Care Med 2001;164(7):1182–5.
Fata, F, Rathore, R, Schiff, C, Herzlich, BC.Bronchiolitis obliterans organizing pneumonia as the first manifestation of polymyositis. South Med J 1997;90(2):227–30.
Lee, CS, Chen, TL, Tzen, CY, et al. Idiopathic inflammatory myopathy with diffuse alveolar damage. Clin Rheumatol 2002;21(5):391–6.
Yamanishi, Y, Maeda, H, Konishi, F, et al. Dermatomyositis associated with rapidly progressive fatal interstitial pneumonitis and pneumomediastinum. Scand J Rheumatol 1999;28(1):58–61.
Nagai, Y, Ishikawa, O, Miyachi, Y.Pneumomediastinum and subcutaneous emphysema associated with fatal interstitial pneumonia in dermatomyositis. J Dermatol 1997;24(7):482–4.
Matsushita, T, Hasegawa, M, Fujimoto, M, et al. Clinical evaluation of anti-aminoacyl tRNA synthetase antibodies in Japanese patients with dermatomyositis. J Rheumatol 2007;34(5):1012–8.
Yousem, SA, Gibson, K, Kaminski, N, Oddis, CV, Ascherman, DP.The pulmonary histopathologic manifestations of the anti-Jo-1 tRNA synthetase syndrome. Mod Pathol 2010;23:874–80.
Beasley, MB, Franks, TJ, Galvin, JR, Gochuico, B, Travis, WD.Acute fibrinous and organizing pneumonia: a histological pattern of lung injury and possible variant of diffuse alveolar damage. Arch Pathol Lab Med 2002;126(9):1064–70.
Prahalad, S, Bohnsack, JF, Maloney, CG, Leslie, KO.Fatal acute fibrinous and organizing pneumonia in a child with juvenile dermatomyositis. J Pediatr 2005;146(2):289–92.
Kawakami, T, Mizoguchi, M, Saito, R, Soma, Y.Histopathological evidence of small-vessel vasculitis within the skin and lungs associated with interstitial pneumonia in an adult patient with dermatomyositis. Clin Exp Dermatol 2008;33(4):415–7.
Lakhanpal, S, Lie, JT, Conn, DL, Martin, WJ. Pulmonary disease in polymyositis/dermatomyositis: a clinicopathological analysis of 65 autopsy cases. Ann Rheum Dis 1987;46(1):23–9.
Schwarz, MI.Pulmonary and cardiac manifestations of polymyositis-dermatomyositis. J Thorac Imaging 1992;7(2):46–54.
Bunch, TW, Tancredi, RG, Lie, JT.Pulmonary hypertension in polymyositis. Chest 1981;79(1):105–7.
Marie, I, Hachulla, E, Cherin, P, et al. Opportunistic infections in polymyositis and dermatomyositis. Arthritis Rheum 2005;53(2):155–65.
Dickey, BF, Myers, AR.Pulmonary disease in polymyositis/dermatomyositis. Semin Arthritis Rheum 1984;14(1):60–76.
Braun, NM, Arora, NS, Rochester, DF.Respiratory muscle and pulmonary function in polymyositis and other proximal myopathies. Thorax 1983;38(8):616–23.
Sigurgeirsson, B, Lindelof, B, Edhag, O, Allander, E.Risk of cancer in patients with dermatomyositis or polymyositis. A population-based study. N Engl J Med 1992;326(6):363–7.
Alam, M, Morehead, RS, Weinstein, MH.Dermatomyositis as a presentation of pulmonary inflammatory pseudotumor (Myofibroblastic tumor). Chest 2000;117(6):1793–5.
Zang, YS, Xiu, QY, Fang, Z, Li, B, Xia, TB.Case report: dramatic recovery of lung adenocarcinoma-associated dermatomyositis with targeted lung cancer therapy alone. Oncologist 2008;13(1):79–81.
Sharp, GC, Irvin, WS, Tan, EM, Gould, RG, Holman, HR.Mixed connective tissue disease – an apparently distinct rheumatic disease syndrome associated with a specific antibody to an extractable nuclear antigen (ENA). Am J Med 1972;52(2):148–59.
Sharp, GC, Irvin, WS, May, CM, et al. Association of antibodies to ribonucleoprotein and Sm antigens with mixed connective-tissue disease, systematic lupus erythematosus and other rheumatic diseases. N Engl J Med 1976;295(21):1149–54.
Maddison, PJ.Mixed connective tissue disease: overlap syndromes. Baillieres Best Pract Res Clin Rheumatol 2000;14(1):111–24.
Venables, PJ.Mixed connective tissue disease. Lupus 2006;15(3):132–7.
Aringer, M, Smolen, JS.Mixed connective tissue disease: what is behind the curtain?Best Pract Res Clin Rheumatol 2007;21(6):1037–49.
Bodolay, E, Szekanecz, Z, Devenyi, K, et al. Evaluation of interstitial lung disease in mixed connective tissue disease (MCTD). Rheumatology (Oxford) 2005;44(5):656–61.
Prakash, UB.Respiratory complications in mixed connective tissue disease. Clin Chest Med 1998;19(4):733–46, ix.
Evans, J.Antinuclear antibody testing in systemic autoimmune disease. Clin Chest Med 1998;19(4):613–25, vii.
Sullivan, WD, Hurst, DJ, Harmon, CE, et al. A prospective evaluation emphasizing pulmonary involvement in patients with mixed connective tissue disease. Medicine (Baltimore) 1984;63(2):92–107.
Wiener-Kronish, JP, Solinger, AM, Warnock, ML, et al. Severe pulmonary involvement in mixed connective tissue disease. Am Rev Respir Dis 1981;124(4):499–503.
Saito, Y, Terada, M, Takada, T, et al. Pulmonary involvement in mixed connective tissue disease: comparison with other collagen vascular diseases using high resolution CT. J Comput Assist Tomogr 2002;26(3):349–57.
Kozuka, T, Johkoh, T, Honda, O, et al. Pulmonary involvement in mixed connective tissue disease: high-resolution CT findings in 41 patients. J Thorac Imaging 2001;16(2):94–8.
Katzenstein, AL, Myers, JL, Prophet, WD, Corley, LS, Shin, MS.Bronchiolitis obliterans and usual interstitial pneumonia. A comparative clinicopathologic study. Am J Surg Pathol 1986;10:373–81.
Parambil, JG, Myers, JL, Aubry, MC, Ryu, JH.Causes and prognosis of diffuse alveolar damage diagnosed on surgical lung biopsy. Chest 2007;132(1):50–7.
Scully, RE, Mark, EJ, McNeely, WF, Ebeling, SH, Phillips, LD.Case records of the Massachusetts General Hospital. Weekly clinicopathological exercises. Case 20–1997. A 74-year-old man with progressive cough, dyspnea, and pleural thickening. N Engl J Med 1997;336(26):1895–903.
Hosoda, Y, Suzuki, Y, Takano, M, Tojo, T, Homma, M.Mixed connective tissue disease with pulmonary hypertension: a clinical and pathological study. J Rheumatol 1987;14(4):826–30.
Burdt, MA, Hoffman, RW, Deutscher, SL, et al. Long-term outcome in mixed connective tissue disease: longitudinal clinical and serologic findings. Arthritis Rheum 1999;42(5):899–909.
Ueda, N, Mimura, K, Maeda, H, et al. Mixed connective tissue disease with fatal pulmonary hypertension and a review of literature. Virchows Arch A Pathol Anat Histopathol 1984;404(4):335–40.
Eulderink, F, Cats, A.Fatal primary pulmonary hypertension in mixed connective tissue disease. Z Rheumatol 1981 Jan-Feb;40(1):25–9.
Kobayashi, H, Sano, T, Ii, K, et al. Mixed connective tissue disease with fatal pulmonary hypertension. Acta Pathol Jpn 1982;32(6):1121–9.
Zhang, L, Visscher, D, Rihal, C, Aubry, MC.Pulmonary veno-occlusive disease as a primary cause of pulmonary hypertension in a patient with mixed connective tissue disease. Rheumatol Int 2007;27(12):1163–5.
Sanchez-Guerrero, J, Cesarman, G, Alarcon-Segovia, D.Massive pulmonary hemorrhage in mixed connective tissue diseases. J Rheumatol 1989;16(8):1132–4.
Germain, MJ, Davidman, M.Pulmonary hemorrhage and acute renal failure in a patient with mixed connective tissue disease. Am J Kidney Dis 1984;3(6):420–4.
Kitaura, K, Miyagawa, T, Asano, K, et al. Mixed connective tissue disease associated with MPO-ANCA-positive polyangiitis. Intern Med 2006;45(20):1177–82.
Komatireddy, GR, Wang, GS, Sharp, GC, Hoffman, RW.Antiphospholipid antibodies among anti-U1–70 kDa autoantibody positive patients with mixed connective tissue disease. J Rheumatol 1997;24(2):319–22.
Mosca, M, Tani, C, Bombardieri, S.Undifferentiated connective tissue diseases (UCTD): a new frontier for rheumatology. Best Pract Res Clin Rheumatol 2007;21(6):1011–23.
Mosca, M, Neri, R, Bombardieri, S.Undifferentiated connective tissue diseases (UCTD): a review of the literature and a proposal for preliminary classification criteria. Clin Exp Rheumatol 1999 Sep-Oct;17(5):615–20.
Kinder, BW, Collard, HR, Koth, L, et al. Idiopathic nonspecific interstitial pneumonia: lung manifestation of undifferentiated connective tissue disease?Am J Respir Crit Care Med 2007;176(7):691–7.
Campbell, AH, Macdonald, CB.Upper lobe fibrosis associated with ankylosing spondylitis. Br J Dis Chest 1965;59:90–101.
Rosenow, E, Strimlan, CV, Muhm, JR, Ferguson, RH.Pleuropulmonary manifestations of ankylosing spondylitis. Mayo Clin Proc 1977;52(10):641–9.
Levy, H, Hurwitz, MD, Strimling, M, Zwi, S.Ankylosing spondylitis lung disease and Mycobacterium scrofulaceum. Br J Dis Chest 1988;82(1):84–7.
Pamuk, ON, Harmandar, O, Tosun, B, Yoruk, Y, Cakir, N.A patient with ankylosing spondylitis who presented with chronic necrotising aspergillosis: report on one case and review of the literature. Clin Rheumatol 2005;24(4):415–9.
El Maghraoui, A, Chaouir, S, Abid, A, et al. Lung findings on thoracic high-resolution computed tomography in patients with ankylosing spondylitis. Correlations with disease duration, clinical findings and pulmonary function testing. Clin Rheumatol 2004;23(2):123–8.
Souza, AS, Muller, NL, Marchiori, E, Soares-Souza, LV, de Souza Rocha, M.Pulmonary abnormalities in ankylosing spondylitis: inspiratory and expiratory high-resolution CT findings in 17 patients. J Thorac Imaging 2004;19(4):259–63.
Sampaio-Barros, PD, Cerqueira, EM, Rezende, SM, et al. Pulmonary involvement in ankylosing spondylitis. Clin Rheumatol 2007;26(2):225–30.
Senocak, O, Manisali, M, Ozaksoy, D, Sevinc, C, Akalin, E.Lung parenchyma changes in ankylosing spondylitis: demonstration with high resolution CT and correlation with disease duration. Eur J Radiol 2003;45(2):117–22.
Kiris, A, Ozgocmen, S, Kocakoc, E, Ardicoglu, O, Ogur, E.Lung findings on high resolution CT in early ankylosing spondylitis. Eur J Radiol 2003;47(1):71–6.
Fenlon, HM, Casserly, I, Sant, SM, Breatnach, E.Plain radiographs and thoracic high-resolution CT in patients with ankylosing spondylitis. AJR Am J Roentgenol 1997;168(4):1067–72.
Turetschek, K, Ebner, W, Fleischmann, D, et al. Early pulmonary involvement in ankylosing spondylitis: assessment with thin-section CT. Clin Radiol 2000;55(8):632–6.
van Noord, JA, Cauberghs, M, Van de Woestijne, KP, Demedts, M.Total respiratory resistance and reactance in ankylosing spondylitis and kyphoscoliosis. Eur Respir J 1991;4(8):945–51.
Jaksch-Wartehnorst, R.Polychondropathia. Wein Archives of Internal Medicine 1923;6:93–100.
Lee-Chiong, TL. Pulmonary manifestations of ankylosing spondylitis and relapsing polychondritis. Clin Chest Med 1998;19(4):747–57, ix.
Gergely, P, Poor, G.Relapsing polychondritis. Best Pract Res Clin Rheumatol 2004;18(5):723–38.
Rapini, RP, Warner, NB.Relapsing polychondritis. Clin Dermatol 2006 Nov-Dec;24(6):482–5.
Prince, JS, Duhamel, DR, Levin, DL, Harrell, JH, Friedman, PJ.Nonneoplastic lesions of the tracheobronchial wall: radiologic findings with bronchoscopic correlation. Radiographics 2002;22 Spec No:S215–30.
Staats, BA, Utz, JP, Michet, CJ. Relapsing polychondritis. Semin Respir Crit Care Med 2002;23(2):145–54.
Michet, CJ, McKenna, CH, Luthra, HS, O'Fallon, WM.Relapsing polychondritis. Survival and predictive role of early disease manifestations. Ann Intern Med 1986;104(1):74–8.
Eng, J, Sabanathan, S.Airway complications in relapsing polychondritis. Ann Thorac Surg 1991;51(4):686–92.
Lee, KS, Ernst, A, Trentham, DE, et al. Relapsing polychondritis: prevalence of expiratory CT airway abnormalities. Radiology 2006;240(2):565–73.
Boulware, DW, Weissman, DN, Doll, NJ.Pulmonary manifestations of the rheumatic diseases. Clin Rev Allergy 1985;3(2):249–67.
Burlew, BP, Lippton, H, Klinestiver, D, Haponik, EJ.Relapsing polychondritis: new pulmonary manifestations. J La State Med Soc 1992;144(2):58–62.
Tanoue, LT.Pulmonary involvement in collagen vascular disease: a review of the pulmonary manifestations of the Marfan syndrome, ankylosing spondylitis, Sjögren's syndrome, and relapsing polychondritis. J Thorac Imaging 1992;7(2):62–77.
Behçet, H.Über rezidivierende Aphtöse, durch ein Virus verursachte Geschwüre am Mund, am Auge und an den Genitalien. Dermatologische Woochenschr 1937;105:1152–7.
Shimizu, T, Ehrlich, GE, Inaba, G, Hayashi, K.Behçet disease (Behçet syndrome). Semin Arthritis Rheum 1979;8(4):223–60.
O'Duffy, JD, Carney, JA, Deodhar, S.Behçet's disease. Report of 10 cases, 3 with new manifestations. Ann Intern Med 1971;75(4):561–70.
Chajek, T, Fainaru, M.Behçet's disease. Report of 41 cases and a review of the literature. Medicine (Baltimore) 1975;54(3):179–96.
Lakhanpal, S, Tani, K, Lie, JT, et al. Pathologic features of Behçet's syndrome: a review of Japanese autopsy registry data. Hum Pathol 1985;16(8):790–5.
Matsumoto, T, Uekusa, T, Fukuda, Y.Vasculo-Behçet's disease: a pathologic study of eight cases. Hum Pathol 1991;22(1):45–51.
Erkan, F, Gul, A, Tasali, E.Pulmonary manifestations of Behçet's disease. Thorax 2001;56(7):572–8.
Criteria for diagnosis of Behçet's disease. International Study Group for Behçet's Disease. Lancet 1990;335(8697):1078–80.
Uzun, O, Akpolat, T, Erkan, L.Pulmonary vasculitis in Behçet disease: a cumulative analysis. Chest 2005;127(6):2243–53.
Hiller, N, Lieberman, S, Chajek-Shaul, T, Bar-Ziv, J, Shaham D. Thoracic manifestations of Behçet disease at CT. Radiographics 2004;24(3):801–8.
Slavin, RE, de Groot, WJ.Pathology of the lung in Behçet's disease. Case report and review of the literature. Am J Surg Pathol 1981;5(8):779–88.
Uzun, O, Erkan, L, Akpolat, I, et al. Pulmonary involvement in Behçet's disease. Respiration 2008;75(3):310–21.
Gamble, CN, Wiesner, KB, Shapiro, RF, Boyer, WJ.The immune complex pathogenesis of glomerulonephritis and pulmonary vasculitis in Behçet's disease. Am J Med 1979;66(6):1031–9.
Green, RJ, Ruoss, SJ, Kraft, SA, et al. Pulmonary capillaritis and alveolar hemorrhage. Update on diagnosis and management. Chest 1996;110(5):1305–16.
Tunaci, M, Ozkorkmaz, B, Tunaci, A, et al. CT findings of pulmonary artery aneurysms during treatment for Behçet's disease. AJR Am J Roentgenol 1999;172(3):729–33.
Erkan, D, Yazici, Y, Sanders, A, Trost, D, Yazici, H.Is Hughes-Stovin syndrome Behçet's disease?Clin Exp Rheumatol 2004 Jul-Aug;22(4 Suppl 34):S64–8.
Emad, Y, Ragab, Y, Shawki Ael, H, et al. Hughes-Stovin syndrome: is it incomplete Behçet's? Report of two cases and review of the literature. Clin Rheumatol 2007;26(11):1993–6.
Durieux, P, Bletry, O, Huchon, G, et al. Multiple pulmonary arterial aneurysms in Behçet's disease and Hughes-Stovin syndrome. Am J Med 1981;71(4):736–41.
Francois, MF.Is Hughes-Stovin syndrome a particular expression of Behçet's disease?Chest 1983;83(2):288.
Hughes, JP, Stovin, PG.Segmental pulmonary artery aneurysms with peripheral venous thrombosis. Br J Dis Chest 1959;53(1):19–27.
Powell, FC, Su, WP, Perry, HO.Pyoderma gangrenosum: classification and management. J Am Acad Dermatol 1996;34(3):395–409; quiz 10–2.
Kruger, S, Piroth, W, Amo, Takyi B, Breuer, C, Schwarz, ER.Multiple aseptic pulmonary nodules with central necrosis in association with pyoderma gangrenosum. Chest 2001;119(3):977–8.
Chahine, B, Chenivesse, C, Tillie-Leblond, I, et al. Pulmonary manifestations of Pyoderma gangrenosum. Presse Med 2007;36(10 Pt 1):1395–8.
Kasuga, I, Yanagisawa, N, Takeo, C, et al. Multiple pulmonary nodules in association with pyoderma gangrenosum. Respir Med 1997;91(8):493–5.
Wang, JL, Wang, JB, Zhu, YJ.Pyoderma gangrenosum with lung injury. Thorax 1999;54(10):953–5.
Brown, TS, Marshall, GS, Callen, JP.Cavitating pulmonary infiltrate in an adolescent with pyoderma gangrenosum: a rarely recognized extracutaneous manifestation of a neutrophilic dermatosis. J Am Acad Dermatol 2000;43(1 Pt 1):108–12.
Field, S, Powell, FC, Young, V, Barnes, L.Pyoderma gangrenosum manifesting as a cavitating lung lesion. Clin Exp Dermatol 2008;33(4):418–21.
Vignon-Pennamen, MD, Zelinsky-Gurung, A, Janssen, F, Frija, J, Wallach, D.Pyoderma gangrenosum with pulmonary involvement. Arch Dermatol 1989;125(9):1239–42.
Kanoh, S, Kobayashi, H, Sato, K, Motoyoshi, K, Aida, S.Tracheobronchial pulmonary disease associated with pyoderma gangrenosum. Mayo Clin Proc 2009;84(6):555–7.
Micali, G, Cook, B, Ronan, S, Yadgir, J, Solomon, LM.Cephalic pyoderma gangrenosum (PG)-like lesions as a presenting sign of Wegener's granulomatosis. Int J Dermatol 1994;33(7):477–80.
Wong, YW, Lyon, CC, Benbow, EW, Bradley, BL, Beck, MH.Pyoderma gangrenosum in a thoracotomy wound associated with a pulmonary cavitating lesion. Clin Exp Dermatol 2003;28(3):274–6.
Sweet, RD.An acute febrile neutrophilic dermatosis. Br J Dermatol 1964 Aug-Sep;76:349–56.
von den Driesch, P.Sweet's syndrome (acute febrile neutrophilic dermatosis). J Am Acad Dermatol 1994;31(4):535–56; quiz 57–60.
Fett, DL, Gibson, LE, Su, WP.Sweet's syndrome: systemic signs and symptoms and associated disorders. Mayo Clin Proc 1995;70(3):234–40.
Jordaan, HF.Acute febrile neutrophilic dermatosis. A histopathological study of 37 patients and a review of the literature. Am J Dermatopathol 1989;11(2):99–111.
Gibson, LE, Dicken, CH, Flach, DB.Neutrophilic dermatoses and myeloproliferative disease: report of two cases. Mayo Clin Proc 1985;60(11):735–40.
Bourke, SJ, Quinn, AG, Farr, PM, Ashcroft, T, Gibson, GJ.Neutrophilic alveolitis in Sweet's syndrome. Thorax 1992;47(7):572–3.
Astudillo, L, Sailler, L, Launay, F, et al. Pulmonary involvement in Sweet's syndrome: a case report and review of the literature. Int J Dermatol 2006;45(6):677–80.
Takimoto, CH, Warnock, M, Golden, JA.Sweet's syndrome with lung involvement. Am Rev Respir Dis 1991;143(1):177–9.
Ladhani, S, Kamble, RT, Sundaram, P, Joshi, JM.Non responding pneumonia with skin lesions. Indian J Chest Dis Allied Sci 2001 Apr-Jun;43(2):115–7.
Imanaga, T, Hayashi, T, Yoshii, C, et al. [Pulmonary involvement in acute febrile neutrophilic dermatosis (Sweet's syndrome)]. Nihon Kokyuki Gakkai Zasshi 2000;38(3):206–10.
Cohen, PR, Kurzrock, R.Extracutaneous manifestations of Sweet's syndrome: steroid-responsive culture-negative pulmonary lesions. Am Rev Respir Dis 1992;146(1):269.
Thurnheer, R, Stammberger, U, Hailemariam, S, Russi, EW.Bronchial manifestation of acute febrile neutrophilic dermatosis (Sweet's syndrome). Eur Respir J 1998;11(4):978–80.
Soderstrom, RM.Sweet's syndrome and acute myelogenous leukemia: a case report and review of the literature. Cutis 1981;28(3):255–7, 60.
Aydemir, H, Oztoprak, N, Celebi, G, et al. Pulmonary and central nervous system involvement in Sweet's syndrome: a very rare case report. Intern Med 2008;47(16):1481–4.
Reid, PT, Alderdice, J, Carson, J, Sinnamon, DG.Cryptogenic organizing pneumonia in association with Sweet's syndrome. Respir Med 1996;90(1):57–9.
Longo, MI, Pico, M, Bueno, C, et al. Sweet's syndrome and bronchiolitis obliterans organizing pneumonia. Am J Med 2001;111(1):80–1.
Camus, P, Colby, TV.The lung in inflammatory bowel disease. Eur Respir J 2000;15(1):5–10.
Camus, P, Piard, F, Ashcroft, T, Gal, AA, Colby, TV.The lung in inflammatory bowel disease. Medicine (Baltimore) 1993;72(3):151–83.
Casey, MB, Tazelaar, HD, Myers, JL, et al. Noninfectious lung pathology in patients with Crohn's disease. Am J Surg Pathol 2003;27(2):213–9.
Bentur, L, Lachter, J, Koren, I, et al. Severe pulmonary disease in association with Crohn's disease in a 13-year-old girl. Pediatr Pulmonol 2000;29(2):151–4.
Shulimzon, T, Rozenman, J, Perelman, M, Bardan, E, Ben-Dov, I.Necrotizing granulomata in the lung preceding colonic involvement in 2 patients with Crohn's disease. Respiration 2007;74(6):698–702.
Kemeny, JL, Andre, M, Charlotte, F, et al. [Aseptic abscesses in eight patients with cryptogenic inflammatory bowel disease]. Ann Pathol 1999;19(4):294–8.
Stebbing, J, Askin, F, Fishman, E, Stone, J.Pulmonary manifestations of ulcerative colitis mimicking Wegener's granulomatosis. J Rheumatol 1999;26(7):1617–21.